Table 5 Univariate and multivariate logistic regression analysis of factors associated with smoking cessation based on concomitant diseases.

P value

OR (95% CI)

P value

OR (95% CI)

COPD

 None

Reference

 Mild

0.004

2.518 (1.335–4.751)

 Moderate

 < 0.001

4.624 (2.585–8.269)

 Severe

 < 0.001

10.320 (5.910–18.022)

Hypoxemia

 None

Reference

Reference

 Mild

 < 0.001

4.569 (2.431–8.589)

0.586

5.587 (1.755–17.791)

 Moderate

 < 0.001

12.629 (6.871–23.213)

0.003

32.973 (9.859–110.274)

 Severe

 < 0.001

20.055 (10.975–36.647)

0.040

21.961 (9.248–121.450)

 Asthma

 < 0.001

4.432 (2.887–6.803)

0.012

3.373 (1.312–8.671)

 Hypertension

 < 0.001

5.538 (3.678–8.340)

 < 0.001

5.978 (2.543–14.054)

 Coronary heart disease

 < 0.001

5.992 (3.895–9.217)

 < 0.001

8.572 (3.377–21.758)

 Myocardial infarction

 < 0.001

3.451 (1.988–5.991)

0.018

4.219 (1.286–13.835)

 Fatty liver

 < 0.001

4.409 (2.909–6.683)

 Diabetes

 < 0.001

5.909 (3.916–8.922)

 < 0.001

6.708 (2.806–16.039)

 Hyperlipidemia

 < 0.001

8.002 (5.227–12.248)

 < 0.001

8.242 (3.433–19.790)

 Hyperuricemia

 < 0.001

5.312 (3.505–8.051)

 < 0.001

5.829 (2.386–14.238)

 Gout

 < 0.001

3.891 (2.338–6.475)

 Metabolic syndrome

 < 0.001

5.190 (3.456–7.794)

 < 0.001

3.304 (1.391–7.850)

 Obesity

 < 0.001

14.944 (8.717–25.617)

 Lacunar infarction

 < 0.001

4.415 (2.585–7.543)

 Arteriosclerosis in the lower extremity

 < 0.001

3.965 (2.456–6.400)

0.040

2.844 (1.050–7.706)

 Carotid atherosclerosis

 < 0.001

3.292 (1.981–5.469)

 Cerebral arteriosclerosis

 < 0.001

5.881 (3.535–9.782)

 Old cerebral infarction

 < 0.001

8.142 (4.483–14.787)